ABSTRACT
The effects of transient mood states on semantic memory organization and use were investigated using event-related potentials. Participants read sentence pairs ending with (1) the most expected word, (2) an unexpected word from the expected semantic category, or (3) an unexpected word from a different (related) category; half the pairs were read under neutral mood and half under positive mood. Under neutral mood, N400 amplitudes were smallest for expected items and smaller for unexpected items when these came from the expected category. In contrast, under positive mood, N400 amplitudes to the two types of unexpected items did not differ. Positive mood seemed to specifically facilitate the processing of distantly-related, unexpected items. The results suggest that transient mood states are associated with dynamic changes in how semantic memory is used on-line.
Subject(s)
Affect/physiology , Evoked Potentials/physiology , Language , Memory/physiology , Adult , Electroencephalography , Female , Humans , Male , Reference Values , Sex Characteristics , Time FactorsABSTRACT
UNLABELLED: Objective. To examine the cross-sectional prevalence of neurological symptoms and signs in a large cohort of human immunodeficiency virus (HIV)-seropositive men, and determine the relationship of the symptoms to disease stage, immunologic markers, and independent variables from neuropsychological (NP) testing and psychiatric interview. METHODS: One hundred-nine controls and 386 HIV-infected volunteers enrolled in the HIV Neurobehavioral Research Center (HNRC) longitudinal study. The majority, without acquired immune deficiency syndrome (AIDS), were screened for alcohol/substance abuse; previous diagnosis of HIV-associated dementia; and HIV-unrelated developmental, neurological, medical, and neurobehavioral conditions which potentially impair cognition; and underwent a structured neurological interview and examination, standardized NP testing, and psychiatric interview as part of a more extensive battery. A large subset (N = 377) underwent lumbar puncture for cerebrospinal fluid (CFS) examination. We examined the relationship of sixteen select but independent variables, using stepwise multiple regressions, from demographic/staging, immunological, NP, and psychiatric domains to neurological symptoms in an effort to identify possible predictors of subclinical nervous systems involvement. Results. All categories of neurological symptoms were significantly more prevalent among medically asymptomatic (CDC stage A) subjects than controls, with a further rise in prevalence in those with more advanced stages of infection. The most marked rise was seen in cognitive and sensorimotor complaints. In contrast, significant findings on neurological examination were evident in only the sicker (stage C) subjects. Stage of illness, serum β2-microglobulin, psychiatric indices of depressed mood or anxiety, and NP "motor" performance were the most significant independent variables associated with the presence of neurological symptoms. CSF pleocytosis was seen early (CDC stage A), and may reflect the presence of HIV in the central nervous system (CNS) at the least stages of infection. We also confirmed the value of CSF β2m and neopterin as important markers of advancing disease stage. Whether they predict subclinical CNS involvement is to be determined by longitudinal observations. Conclusion. Neurological complains are common in medically asymptomatic HIV subjects whereas signs are not. The symptoms correlate with commonly determined independent measures of depression, anxiety, NP tests of fine motor speed and strength, as well as indices of disease worsening (CDC stage, serum β2m).
Subject(s)
HIV Infections , Longitudinal Studies , AIDS Dementia Complex/diagnosis , Acquired Immunodeficiency Syndrome , Cross-Sectional Studies , HIV Seropositivity , Humans , Neuropsychological TestsABSTRACT
The present study examined neuropsychological (NP) functioning and associated medical, neurological, brain magnetic resonance imaging (MRI), and psychiatric findings in 389 nondemented males infected with Human Immunodeficiency Virus-Type 1 (HIV-1), and in 111 uninfected controls. Using a comprehensive NP test battery, we found increased rates of impairment at each successive stage of HIV infection. HIV-related NP impairment was generally mild, especially in the medically asymptomatic stage of infection, and most often affected attention, speed of information processing, and learning efficiency; this pattern is consistent with earliest involvement of subcortical or frontostriatal brain systems. NP impairment could not be explained on the bases of mood disturbance, recreational drug or alcohol use, or constitutional symptoms; by contrast, impairment in HIV-infected subjects was related to central brain atrophy on MRI, as well as to evidence of cellular immune activation and neurological abnormalities linked to the central nervous system.
Subject(s)
AIDS Dementia Complex/diagnosis , HIV Infections/diagnosis , HIV-1 , Neuropsychological Tests/statistics & numerical data , AIDS Dementia Complex/classification , AIDS Dementia Complex/psychology , Adult , Brain Mapping , HIV Infections/classification , HIV Infections/psychology , Humans , Magnetic Resonance Imaging , Male , Psychometrics , Reference ValuesABSTRACT
In the present study, the California Verbal Learning Test (CVLT) was administered to symptomatic HIV+ (n = 31), asymptomatic HIV+ (n = 94), and HIV-normal control (HIV-NC) (n = 40) subjects to assess the prevalence and nature of their verbal memory deficits. Symptomatic HIV+ subjects were significantly impaired relative to HIV-control subjects on CVLT measures of acquisition and retention, and were significantly less likely than control subjects to use a semantic clustering strategy to support recall. The performance of the asymptomatic HIV+ subjects fell between those of the symptomatic HIV+ subjects and HIV-controls on almost every CVLT measure. A linear discriminant function analysis (DFA) was used to compare the performances of these three groups to Alzheimer's disease (AD). Huntington's disease (HD), and normal control (NC) subjects on three CVLT measures, including total recall over five learning trials, intrusion errors, and a derived score of delayed recognition discriminability minus the final learning trial. Significant differences were found between the number of symptomatic HIV+ subjects classified as HD (32%), AD (3%), and normal (65%), the number of asymptomatic HIV+ subjects classified as HD (16%), AD (1%), and normal (83%), and the number of HIV-NC subjects classified as HD (2%), AD (0%), and normal (98%). The profile of verbal memory deficits exhibited by the subgroup of impaired HIV+ subjects was similar to that of patients with HD, a prototypical subcortical dementia, and different from that of patients with AD, a prototypical cortical dementia. This finding is consistent with reports of the predominance of subcortical neuropathological changes associated with HIV infection.
Subject(s)
AIDS Dementia Complex/physiopathology , Cerebral Cortex/physiopathology , Mental Recall/physiology , Verbal Learning/physiology , AIDS Dementia Complex/diagnosis , AIDS Dementia Complex/psychology , Adult , Alzheimer Disease/diagnosis , Alzheimer Disease/physiopathology , Alzheimer Disease/psychology , Attention/physiology , Brain Damage, Chronic/diagnosis , Brain Damage, Chronic/physiopathology , Brain Damage, Chronic/psychology , HIV Seropositivity/diagnosis , HIV Seropositivity/physiopathology , HIV Seropositivity/psychology , Humans , Huntington Disease/diagnosis , Huntington Disease/physiopathology , Huntington Disease/psychology , Male , Middle Aged , Neuropsychological Tests/statistics & numerical data , Psychometrics , Retention, Psychology/physiologyABSTRACT
Individuals infected with the human immunodeficiency virus-Type 1 (HIV-1), are at increased risk for neurobehavioral impairment, particularly in later stages of the disease. Even patients in the medically asymptomatic or minimally symptomatic stages of infection may show mild deficits on comprehensive neuropsychological (NP) test batteries, although the clinical significance of such deficits remains uncertain. The present study used vocational difficulties as markers of clinical significance of NP impairment. In a sample of 289 HIV-infected, nondemented men, those who evidenced NP impairment had a higher unemployment rate (p < .001) than did their unimpaired counterparts. In HIV-positive subjects who remained employed, NP impairment was strongly associated with subjective decreases in job-related abilities. Neither depression nor medical symptoms could explain the relationship between the NP impairment and employment problems. These results are consistent with previous studies investigating other neuropsychiatric disorders, which suggest that even mild NP impairment can interfere with employment status. From this standpoint, such impairment in HIV-infected persons may be described as "clinically significant."
Subject(s)
AIDS Dementia Complex/rehabilitation , HIV-1 , Neuropsychological Tests , Rehabilitation, Vocational , AIDS Dementia Complex/diagnosis , AIDS Dementia Complex/transmission , Adult , California , Disability Evaluation , HIV Seropositivity/diagnosis , HIV Seropositivity/rehabilitation , HIV Seropositivity/transmission , Humans , Longitudinal Studies , Male , Military Personnel/statistics & numerical data , Sexual Behavior , Unemployment/statistics & numerical dataABSTRACT
Elevated levels of beta 2-microglobulin and neopterin in cerebrospinal fluid (CSF) have been associated with neurologic complications of infection with the human immunodeficiency virus (HIV). The effect of zidovudine (ZDV) on these markers was assessed by studying the effect of ZDV treatment duration on CSF levels in a cohort of 145 HIV-positive men who were receiving ZDV. CSF beta 2-microglobulin and neopterin levels were significantly lower in those who had been taking ZDV for an intermediate period of time (46-365 days) than in those who had received ZDV either long term (> 365 days) or short term (1-45 days). CSF quinolinic acid levels were independent of duration of ZDV administration. A second CSF evaluation was available after 1 year for 54 HIV-positive men (19 of whom were also in the first cohort) and 11 HIV-negative controls. Patients who had started ZDV between lumbar punctures showed a significant decrease in CSF beta 2-microglobulin, but in those who had been receiving ZDV for > 1 year beta 2-microglobulin increased (p = 0.001). The effect was not observed with neopterin (p = 0.14). (Quinolinic acid levels were not studied longitudinally.) Finally, we observed that CSF levels of beta 2-microglobulin, neopterin, and quinolinic acid correlated strongly with each other in HIV-positive individuals (r = 0.7, p < 0.0001), even though ZDV might have different effects on these markers. In conclusion, we report that initiation of ZDV therapy is associated with a transient decrease in CSF levels of beta 2-microglobulin and neopterin.(ABSTRACT TRUNCATED AT 250 WORDS)
Subject(s)
HIV Seropositivity/cerebrospinal fluid , Zidovudine/therapeutic use , Adult , Biopterins/analogs & derivatives , Biopterins/cerebrospinal fluid , CD4-Positive T-Lymphocytes , Cerebrospinal Fluid Proteins/analysis , Cohort Studies , Cross-Sectional Studies , Glucose/cerebrospinal fluid , HIV Seropositivity/blood , HIV Seropositivity/drug therapy , Humans , Leukocyte Count , Longitudinal Studies , Male , Middle Aged , Neopterin , Quinolinic Acid/cerebrospinal fluid , beta 2-Microglobulin/cerebrospinal fluidABSTRACT
Recent work on natural categories suggests a framework for conceptualizing people's knowledge about emotions. Categories of natural objects or events, including emotions, are formed as a result of repeated experiences and become organized around prototypes (Rosch, 1978); the interrelated set of emotion categories becomes organized within an abstract-to-concrete hierarchy. At the basic level of the emotion hierarchy one finds the handful of concepts (love, joy, anger, sadness, fear, and perhaps, surprise) most useful for making everyday distinctions among emotions, and these overlap substantially with the examples mentioned most readily when people are asked to name emotions (Fehr & Russell, 1984), with the emotions children learn to name first (Bretherton & Beeghly, 1982), and with what theorists have called basic or primary emotions. This article reports two studies, one exploring the hierarchical organization of emotion concepts and one specifying the prototypes, or scripts, of five basic emotions, and it shows how the prototype approach might be used in the future to investigate the processing of information about emotional events, cross-cultural differences in emotion concepts, and the development of emotion knowledge.